Mineralys Therapeutics, Inc. MLYS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$39.34M+6.8% | -$32.23M+34.1% | -$36.93M+34.5% | -$43.27M-5.5% | -$42.21M-34.0% | ||
| $6K-60.0% | $13K-13.3% | $15K+36.4% | $16K+77.8% | $15K+87.5% | ||
| $6.55M+79.6% | $5.29M+68.6% | $5.84M+86.1% | $4.55M+58.5% | $3.65M+66.4% | ||
| -$39.47M+13.2% | -$37.89M+43.3% | -$28.87M+42.5% | -$30.17M-0.1% | -$45.49M-138% | ||
| -$44.94M+51.6% | -$103.49M-224% | -$150.51M-289% | -$42.88M-654% | -$92.88M-66.0% | ||
| $24.27M-87.2% | $96.7M+107,346% | $295.19M— | $9.83M— | $189.28M+62.9% | ||
| -$60.14M-218% | —— | $115.81M+294% | -$63.22M— | $50.92M+23.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Mineralys Therapeutics, Inc. generate?
- Mineralys Therapeutics, Inc. (MLYS) generated -$136.4M in operating cash flow over the trailing twelve months.
- Where does Mineralys Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Mineralys Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.